Vastuskiri

Dokumendiregister Terviseamet
Viit 11.2-1/24/7771-2
Registreeritud 30.07.2024
Sünkroonitud 31.07.2024
Liik Väljaminev dokument
Funktsioon 11.2 Turustamise eelne järelevalve (pre-marketing surveillance)
Sari 11.2-1 Meditsiiniseadmete kliiniliste uuringute ja toimivusuuringute dokumendid (taotlused, load, muud teavitused ja kirjavahetus)
Toimik 11.2-1/2024
Juurdepääsupiirang Avalik
Juurdepääsupiirang
Adressaat RQM+
Saabumis/saatmisviis RQM+
Vastutaja Merili Saar-Abroi (TA, Peadirektori asetäitja (1) vastutusvaldkond, Meditsiiniseadmete osakond)
Originaal Ava uues aknas

Failid

Vs_ To Medical Devices Department_ List of documents for initial device study application.msg
image001.jpg
image002.png
image003.png
image004.png

From: "Meditsiiniseadmed (Medical Devices)" <mso@terviseamet.ee>
Sent: Tue, 23 Jul 2024 12:16:21 +0000
To: "Luksys; Nerijus" <nluksys@rqmplus.com>
Subject: Vs: To Medical Devices Department: List of documents for initial device study application

Dear Nerijus,

 

Thank You for Your inquiry.

 

An application for a clinical investigation (CI)/performance study (PS) consists of the following:
1. obtaining the opinion of the ethics committee as
per Estonian Medical Devices Act § 22 (1),
2. paying all relevant fees,
3. submitting any necessary documentation for the study.

In Estonia, the competent authority for medical devices and the ethics committees that evaluate medical device clinical investigations and in vitro diagnostic medical device performance studies are separate independent entities. These ethics committees are not required by law to notify us about their existence. To our knowledge there are two ethics committees in our field – Research Ethics Committee of the University of Tartu and Research Ethics Committee of the National Institute for Health Development. As they are independent from the competent authority, the sponsor shall inquire about their timelines and possible fees directly from the ethical committees.

 

After the acquirement of the opinion of the ethics committee and to start the process of  study authorisation by the Health Board, the sponsor is obliged to pay two kinds of fees:

  1. the State Fee of 210 euros,

  2. the Health Board fee according to the type of study conducted.

According to the State Fees Act § 2981, a state fee of 210 euros is paid for the review of an application for a CI/PS. The payment must be made before the application submission to the Health Board. No invoice for this payment will be issued. The details on the payment information can be found below in Table 1.

 

Table 1. Payment information for the State Fee.

Recipient details

Recipient

Ministry of Finance

 

Bank details

Bank

Account number

BIC/SWIFT

SEB Bank

EE891010220034796011

EEUHEE2X

Swedbank

EE932200221023778606

HABAEE2X

LHV Bank

EE777700771003813400

LHVBEE22

Luminor Bank

EE701700017001577198

NDEAEE2X

 

Transaction information

Reference number1

2900083031

1 NB! The reference number is mandatory on bank transfer!

 

In addition to the State fee, the sponsor is obliged to pay the fee to the Health Board for professional assessment of the performance study before the submission of an application for the performance study. The Health Board fee is established in the regulation of the minister in charge of the policy sector § 3 for a CI and § 4 for a PS. The fee can be either 405 euros or 1457 euros depending on the type of the study conducted.

The sponsor must determine the type of fee according to whether the study falls under § 3 (1) or § 3 (2) in case of a CI or under § 4 (1) or § 4 (2) in case of a PS described in the regulation of the minister in charge of the policy sector. We will issue an invoice for the Health Board fee stated above. To issue an invoice for the Health Board fees, we will require the following information:

  • name of the company,

  • registry code,

  • legal address and contact information (e-mail, telephone number and name of contact person),

  • type of fee the sponsor is applying for.

The invoice will be issued to the contact person within 10 days after your request. The invoice must be paid within 40 days since the issue date of the invoice.

 

After obtaining the opinion of an ethics committee and paying relevant fees, the sponsor of a CI/PS is required to submit an application to the Health Board via e-mail: mso@terviseamet.ee. The contents of the documents are throughly described in the Regulation (EU) 2017/745 Chapter VI and Annexes XIV and XV regarding a CI and in the Regulation (EU) 2017/746 Chapter VI and Annexes XIII and XIV regarding a PS. The application form and all other relevant documents for conducting a performance study can be found from the Medical Device Coordination Group guidance documents MDCG 2021-08 Clinical Investigation application/notification documents or from MDCG 2022-19 Performance study application/notification documents under Regulation (EU) 2017/746.  All documents may be drawn in either Estonian or English language, except for the documents used for obtaining the informed consent which must be drawn in the native language of the patient participating in the study.

 

In case of any further questions, please do not hesitate to contact us again.

All the best,

Merili Saar-Abroi

Chief Specialist

Department of Medical Devices

Phone +372 554 3041

merili.saar-abroi@terviseamet.ee  | mso@terviseamet.ee

Terviseamet | Health Board

+372 794 3500

info@terviseamet.ee
www.terviseamet.ee

Paldiski mnt 81, 10614 Tallinn

 

 

This e-mail is confidential and meant for use by the person named in the letterhead. Any use in any way or copying of it by a person not marked as the addressee thereof is prohibited. If you have got this e-mail by mistake, please notify of it the sender without delay and delete the received e-mail together with all its attachments.

 

Saatja: Luksys, Nerijus <nluksys@rqmplus.com>
Saatmisaeg: esmaspäev, 22. juuli 2024 14:44
Adressaat: Meditsiiniseadmed (Medical Devices) <mso@terviseamet.ee>
Teema: To Medical Devices Department: List of documents for initial device study application

 

Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.


 

Dears,

 

I would appreciate it if you could send me the list of documents (or web link with it) needed for the initial submission of the Medical Device Study for CA approval.

Could you please list what is needed for MDR and IVDR studies?  As well please provide the Application Form and other local forms that must be submitted only in Estonian.

 

Could you please confirm that the following price is correct:

„A state fee of 576 euros shall be paid for the review of an application for the permit for a clinical investigation of a medical device, and 27 euros shall be paid for each additional research centre“

 

Thank you in advance for your response.

 

 

Kind regards,

Nerijus

 

Luksys

Senior CRA

T:  +37061124299

 

E: nluksys@rqmplus.com 

LinkedIn

 

Nerijus

 

Luksys

Contract Consultant

E: 

nluksys@rqmplus.com

LinkedIn

Follow RQM+ on LinkedIn

CONFIDENTIALITY NOTICE: The information contained in this message, along with any attachments, is intended solely for the addressee(s) and contains information that is confidential and legally protected under applicable law. If you are not the intended recipient(s), you are notified that the dissemination, distribution or copying of this message is strictly prohibited. If you are not the intended recipient, please notify dpo@rqmplus.com and destroy all copies of the original message, along with any attachments. Thank you for your cooperation.

 

Seosed

Nimi K.p. Δ Viit Tüüp Org Osapooled
Kiri 30.07.2024 1 11.2-1/24/7771-1 Sissetulev dokument ta RQM+